84 related articles for article (PubMed ID: 24375035)
1. The three CARMA sisters: so different, so similar: a portrait of the three CARMA proteins and their involvement in human disorders.
Scudiero I; Vito P; Stilo R
J Cell Physiol; 2014 Aug; 229(8):990-7. PubMed ID: 24375035
[TBL] [Abstract][Full Text] [Related]
2. CARD14/CARMA2 Signaling and its Role in Inflammatory Skin Disorders.
Zotti T; Polvere I; Voccola S; Vito P; Stilo R
Front Immunol; 2018; 9():2167. PubMed ID: 30319628
[TBL] [Abstract][Full Text] [Related]
3. The E3 Ubiquitin Ligase RNF7 Negatively Regulates CARD14/CARMA2sh Signaling.
Telesio G; Scudiero I; Pizzulo M; Mazzone P; Zotti T; Voccola S; Polvere I; Vito P; Stilo R
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29194363
[TBL] [Abstract][Full Text] [Related]
4. The Dishevelled, EGL-10 and pleckstrin (DEP) domain-containing protein DEPDC7 binds to CARMA2 and CARMA3 proteins, and regulates NF-κB activation.
D'Andrea EL; Ferravante A; Scudiero I; Zotti T; Reale C; Pizzulo M; De La Motte LR; De Maio C; Mazzone P; Telesio G; Vito P; Stilo R
PLoS One; 2014; 9(12):e116062. PubMed ID: 25541973
[TBL] [Abstract][Full Text] [Related]
5. Clinical and Genetic Heterogeneity of
Israel L; Mellett M
Front Immunol; 2018; 9():2239. PubMed ID: 30386326
[TBL] [Abstract][Full Text] [Related]
6. Alternative splicing of CARMA2/CARD14 transcripts generates protein variants with differential effect on NF-κB activation and endoplasmic reticulum stress-induced cell death.
Scudiero I; Zotti T; Ferravante A; Vessichelli M; Vito P; Stilo R
J Cell Physiol; 2011 Dec; 226(12):3121-31. PubMed ID: 21302310
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of caspase recruitment domain (CARD) membrane-associated guanylate kinase 1 (CARMA1) and CARD9 in primary gastric B-cell lymphoma.
Nakamura S; Nakamura S; Matsumoto T; Yada S; Hirahashi M; Suekane H; Yao T; Goda K; Iida M
Cancer; 2005 Nov; 104(9):1885-93. PubMed ID: 16177990
[TBL] [Abstract][Full Text] [Related]
8. Generation and functional characterization of a BCL10-inhibitory peptide that represses NF-kappaB activation.
Marasco D; Stilo R; Sandomenico A; Monti SM; Tizzano B; de Capua A; Varricchio E; Liguoro D; Zotti T; Formisano S; Ruvo M; Vito P
Biochem J; 2009 Aug; 422(3):553-61. PubMed ID: 19538180
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of CARMA1/CARD11 and Bob1 as candidate genes in common variable immunodeficiency.
Tampella G; Baronio M; Vitali M; Soresina A; Badolato R; Giliani S; Plebani A; Lougaris V
J Investig Allergol Clin Immunol; 2011; 21(5):348-53. PubMed ID: 21905497
[TBL] [Abstract][Full Text] [Related]
10. Increased epidermal expression and absence of mutations in CARD14 in a series of patients with sporadic pityriasis rubra pilaris.
Eytan O; Qiaoli L; Nousbeck J; van Steensel MA; Burger B; Hohl D; Taïeb A; Prey S; Bachmann D; Avitan-Hersh E; Jin Chung H; Shemer A; Trau H; Bergman R; Fuchs-Telem D; Warshauer E; Israeli S; Itin PH; Sarig O; Uitto J; Sprecher E
Br J Dermatol; 2014 May; 170(5):1196-8. PubMed ID: 24359224
[No Abstract] [Full Text] [Related]
11. A case of bad Carma!
Buchbinder D; Sassoon A
Blood; 2017 Mar; 129(12):1737. PubMed ID: 28336733
[No Abstract] [Full Text] [Related]
12. CARMA1 and chromosomal translocations in extranodal marginal zone B-cell lymphomas of MALT type or diffuse large B-cell lymphomas.
Adam P; Haralambieva E; Greiner A; Ott M; Rosenwald A; Ott G
Haematologica; 2006 Nov; 91(11):1575-6. PubMed ID: 17043017
[TBL] [Abstract][Full Text] [Related]
13. CD28 stimulation triggers NF-kappaB activation through the CARMA1-PKCtheta-Grb2/Gads axis.
Takeda K; Harada Y; Watanabe R; Inutake Y; Ogawa S; Onuki K; Kagaya S; Tanabe K; Kishimoto H; Abe R
Int Immunol; 2008 Dec; 20(12):1507-15. PubMed ID: 18829987
[TBL] [Abstract][Full Text] [Related]
14. Editorial: CARMA Proteins: Playing a Hand of Four CARDs.
Bornancin F; Snow AL
Front Immunol; 2019; 10():1217. PubMed ID: 31231375
[No Abstract] [Full Text] [Related]
15. Protein kinase C inhibitor sotrastaurin selectively inhibits the growth of CD79 mutant diffuse large B-cell lymphomas.
Naylor TL; Tang H; Ratsch BA; Enns A; Loo A; Chen L; Lenz P; Waters NJ; Schuler W; Dörken B; Yao YM; Warmuth M; Lenz G; Stegmeier F
Cancer Res; 2011 Apr; 71(7):2643-53. PubMed ID: 21324920
[TBL] [Abstract][Full Text] [Related]
16. Post-translational modifications regulate distinct functions of CARMA1 and BCL10.
Thome M; Weil R
Trends Immunol; 2007 Jun; 28(6):281-8. PubMed ID: 17468049
[TBL] [Abstract][Full Text] [Related]
17. Gain of function p.E138A alteration in Card14 leads to psoriasiform skin inflammation and implicates genetic modifiers in disease severity.
Sundberg JP; Pratt CH; Silva KA; Kennedy VE; Qin W; Stearns TM; Frost J; Sundberg BA; Bowcock AM
Exp Mol Pathol; 2019 Oct; 110():104286. PubMed ID: 31323190
[TBL] [Abstract][Full Text] [Related]
18. Psoriasis Plays a Wild CARD.
Van Nuffel E; Afonina IS; Beyaert R
J Invest Dermatol; 2018 Sep; 138(9):1903-1905. PubMed ID: 30143077
[TBL] [Abstract][Full Text] [Related]
19. CD4 ligation excludes the Carma1-Bcl10-MALT1 complex from GM1-positive membrane rafts in CD3/CD28 activated T cells.
Rigo M; Chentouf M; Pèlegrin A; Chardès T
Cell Immunol; 2011; 270(1):40-6. PubMed ID: 21489413
[TBL] [Abstract][Full Text] [Related]
20. Self-oligomerization of the CARD domain prevents complex formation in the CARMA1 signalosome.
Park JH; Bae JY; Park HH
Int J Mol Med; 2013 May; 31(5):1280-7. PubMed ID: 23525237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
